Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Pyridam Farma Tbk (PYFA) vs Reksa Dana Indeks Mandiri ETF Sri-Kehati (XMSK) Price & Performance

Pyridam Farma TbkTrade
Reksa Dana Indeks Mandiri ETF Sri-KehatiTrade

Price performance (Past 24H)

Key statistics

Pyridam Farma Tbk vs Reksa Dana Indeks Mandiri ETF Sri-Kehati — how do they compare? Pyridam Farma Tbk trades at Rp216 (market cap 2.38T, 3.37M 24h volume), while Reksa Dana Indeks Mandiri ETF Sri-Kehati trades at Rp342 (market cap 50.1B, 4.5K 24h volume). The key difference: Pyridam Farma Tbk is far larger — about 47.5× Reksa Dana Indeks Mandiri ETF Sri-Kehati's market cap, and Pyridam Farma Tbk is more actively traded (3.37M versus 4.5K). Which is the better fit depends on your goals.

PYFAXMSK
Market Cap
2.38T50.1B
Volume
3.37M4.5K
Lot
33.75K45
Turnover
717.36M1.54M
Average Price
212.56342
Value
717.36M1.54M
Indicative Equilibrium Price
216
Indicative Equilibrium Volume
315

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

PYFA
View details

About Pyridam Farma Tbk

PT. Pyridam Farma Tbk. Founded in Jakarta based on Limited Company Act on November 27th 1976 and start the commercial operation since 1978 which conduct in pharmaceutical business.On its first establishmnent, the corporate produce & distribute medicine products for livestock & pet.. Since 1985 the corporate develop pharmacy division which emphasize produce and distribute health product for human and for livestock held by veterinary division.

Read more on PYFA

About Reksa Dana Indeks Mandiri ETF Sri-Kehati

Read more on XMSK